PAGLIARO, LUCA
 Distribuzione geografica
Continente #
AS - Asia 1.175
NA - Nord America 1.142
EU - Europa 1.020
SA - Sud America 209
AF - Africa 72
OC - Oceania 2
Totale 3.620
Nazione #
US - Stati Uniti d'America 1.091
IT - Italia 546
SG - Singapore 413
VN - Vietnam 260
CN - Cina 229
BR - Brasile 150
DE - Germania 88
HK - Hong Kong 88
FR - Francia 61
NL - Olanda 49
ZA - Sudafrica 45
RU - Federazione Russa 43
IE - Irlanda 40
AT - Austria 39
FI - Finlandia 36
IN - India 33
GB - Regno Unito 28
BD - Bangladesh 26
CA - Canada 26
SE - Svezia 26
AR - Argentina 24
IQ - Iraq 19
MX - Messico 17
KR - Corea 14
ID - Indonesia 13
JP - Giappone 13
PL - Polonia 13
BE - Belgio 10
TR - Turchia 10
PK - Pakistan 9
CZ - Repubblica Ceca 8
PH - Filippine 8
EC - Ecuador 7
UA - Ucraina 7
EG - Egitto 6
ES - Italia 6
LT - Lituania 6
PA - Panama 6
CO - Colombia 5
MA - Marocco 5
PY - Paraguay 5
SA - Arabia Saudita 5
UY - Uruguay 5
AZ - Azerbaigian 4
CI - Costa d'Avorio 4
IL - Israele 4
PE - Perù 4
TH - Thailandia 4
UZ - Uzbekistan 4
VE - Venezuela 4
DZ - Algeria 3
GR - Grecia 3
KE - Kenya 3
MY - Malesia 3
PT - Portogallo 3
TW - Taiwan 3
AU - Australia 2
CL - Cile 2
HR - Croazia 2
LY - Libia 2
NP - Nepal 2
RS - Serbia 2
SY - Repubblica araba siriana 2
AE - Emirati Arabi Uniti 1
BH - Bahrain 1
BO - Bolivia 1
CY - Cipro 1
ET - Etiopia 1
GF - Guiana Francese 1
GP - Guadalupe 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MU - Mauritius 1
NG - Nigeria 1
NO - Norvegia 1
OM - Oman 1
PS - Palestinian Territory 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
TN - Tunisia 1
Totale 3.620
Città #
Ashburn 255
Singapore 242
Parma 152
Dallas 120
San Jose 110
Hong Kong 83
Ho Chi Minh City 82
Santa Clara 80
Boardman 57
Hanoi 50
Milan 48
Beijing 43
Johannesburg 42
Munich 42
Dublin 40
Bologna 34
Los Angeles 34
Ann Arbor 33
Vienna 33
New York 32
Lauterbourg 30
Chandler 27
Shanghai 26
São Paulo 24
Chicago 20
Reggio Emilia 20
Rome 20
Turku 20
Hefei 19
Brescia 17
Haiphong 17
Modena 17
Moscow 17
Buffalo 15
Nuremberg 14
Frankfurt am Main 12
Helsinki 12
Amsterdam 11
Biên Hòa 10
Jakarta 10
Toronto 10
Montreal 9
Seoul 9
Tokyo 9
Warsaw 9
Brussels 8
Carpi 8
Curitiba 8
Fidenza 8
Perugia 8
West Jordan 8
Baghdad 7
Brooklyn 7
Council Bluffs 7
Columbus 6
Orem 6
Rio de Janeiro 6
Chandigarh 5
Da Nang 5
Denver 5
Lahore 5
London 5
Mexico City 5
Naples 5
Poplar 5
Turin 5
Abidjan 4
Atlanta 4
Baku 4
Boston 4
Brasília 4
Bremen 4
Brno 4
Cairo 4
Chennai 4
Concesio 4
Florence 4
Istanbul 4
Nanjing 4
Paris 4
Princeton 4
Querétaro 4
Quito 4
Roubaix 4
Salvador 4
Seattle 4
Tashkent 4
Bengaluru 3
Buenos Aires 3
Cape Town 3
Casalgrande 3
Charlotte 3
City of London 3
Guangzhou 3
Houston 3
Inglewood 3
Jeddah 3
Kochi 3
Montevideo 3
Nha Trang 3
Totale 2.271
Nome #
Blockade of Oncogenic NOTCH1 with the SERCA Inhibitor CAD204520 in T Cell Acute Lymphoblastic Leukemia 253
Discovery of a new 1-(phenylsulfonyl)-1H-indole derivative targeting the EphA2 receptor with antiproliferative activity on U251 glioblastoma cell line 232
Morphological, clinical, and molecular profiling of post-polycythemia vera accelerated/blast phase occurring with and without antecedent secondary myelofibrosis 212
Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemia 208
The -2518 A/G polymorphism of the monocyte chemoattractant protein-1 as a candidate genetic predisposition factor for secondary myelofibrosis and biomarker of disease severity 205
Targeting oncogenic Notch signaling with SERCA inhibitors 185
Identification of the Atypical Protein Kinase WNK1 As a New Target in T-Cell Acute Lymphoblastic Leukemia 147
Targeting Notch Trafficking and Processing in Cancers 142
Genetics of Darier’s Disease: New Insights into Pathogenic Mechanisms 141
CAD204520 Targets NOTCH1 PEST Domain Mutations in Lymphoproliferative Disorders 135
Orthogonal Proteogenomic Approaches Identify the Druggable PA2G4-MYC Axis in 3q26 AML 133
SERCA MODULATION COUNTERACTS GLUCOCORTICOID RESISTANCE IN T-ALL 130
Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML 129
SELECTIVE BLOCKADE OF ONCOGENIC NOTCH1 WITH THE NEW SERCA INHIBITOR CAD204520 125
The Atypical Protein Kinase WNK1 Controls Leukemia Progression in TAL/LMO T-Cell Acute Lymphoblastic Leukemia 124
Acute lymphoblastic leukaemia 123
Myb overexpression synergizes with the loss of Pten and is a dependency factor and therapeutic target in T-cell lymphoblastic leukemia 115
PROGNOSTIC VALUE OF CYTOGENETIC ABERRATIONS AND INTRATUMORAL GENETIC HETEROGENEITY IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) 110
Selective Blockade of Oncogenic NOTCH1 with the New SERCA Inhibitor CAD204520 in T-cell Acute Lymphoblastic Leukemia 103
T(10;11)(P13;P14-21) PICALM-MLLT10 ACUTE LEUKEMIA: CHARACTERIZATION OF TWO CASES WITH DIFFERENT PHENOTYPIC PRESENTATION 93
Modern treatment approaches to adult acute T-lymphoblastic and myeloid/T-lymphoblastic leukemia: From current standards to precision medicine 93
FROM GENOMICS TO CHEMOGEGNOMICS IN T CELL ACUTE LYMPHOBLASTIC LEUKEMIA 91
IMPACT OF TREATMENT WITH IDELALISIB PLUS RITUXIMAB ON CLINICAL AND CYTOGENETICS PROFILE IN RELAPSE/REFRACTORY CLL: THE EXPERIENCE OF THE UNIVERSITY HOSPITAL OF PARMA 88
Targeting the Activating Mutations of NOTCH1 in T-Cell Lymphoblastic Leukemia with a New SERCA Inhibitor CAD204520 80
Ex-vivo drug response profiling guides therapy in a case of high-risk acute undifferentiated leukemia with PICALM::MLLT10 64
A chemotrascriptomic screening identifies the reversal of glucocorticoid resistance in NOTCH1 mutated T-ALL. 54
EHMT2/G9A drives the epigenetic regulation of glucose metabolism in T-cell Acute lymphoblastic leukemia 48
Nidogen-1, a Player in KMT2A-Rearranged Pediatric Acute Myeloid Leukemia 46
Targeting oncogenic NOTCH1 in T-cell acute lymphoblastic leukemia with a new selective serca inhibitor. 44
Drug profiling in a preclinical murine mantle cell lymphoma mouse model identifies novel vulnerabilities. 40
Totale 3.693
Categoria #
all - tutte 11.534
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.534


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202130 0 0 0 0 0 0 0 0 0 16 4 10
2021/202251 3 4 6 4 3 4 11 3 1 3 2 7
2022/2023166 8 19 12 11 31 14 5 7 36 2 17 4
2023/2024259 8 3 4 15 5 18 70 22 14 33 17 50
2024/2025956 33 37 55 81 84 73 77 71 105 71 98 171
2025/20262.142 192 137 271 271 313 148 180 150 307 173 0 0
Totale 3.693